132 related articles for article (PubMed ID: 165418)
21. Altered responsiveness to thyrotropin in thyroid slices of Graves' disease preoperatively treated with excess iodide.
Onaya T; Miyakawa M; Makiuchi M; Furihata R
J Clin Endocrinol Metab; 1978 Aug; 47(2):405-9. PubMed ID: 233671
[TBL] [Abstract][Full Text] [Related]
22. Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
Denereaz N; Lemarchand-Beraud T
Endocrinology; 1995 Apr; 136(4):1694-700. PubMed ID: 7895680
[TBL] [Abstract][Full Text] [Related]
23. Alterations of adrenergic systems in thyroid slices from patients with Graves' disease.
Yamashita K; Aiyoshi Y; Kuzuya N; Koide Y
Acta Endocrinol (Copenh); 1985 Nov; 110(3):360-5. PubMed ID: 2866653
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma inhibition of human thyrotropin receptor gene expression.
Nishikawa T; Yamashita S; Namba H; Usa T; Tominaga T; Kimura H; Izumi M; Nagataki S
J Clin Endocrinol Metab; 1993 Oct; 77(4):1084-9. PubMed ID: 8408457
[TBL] [Abstract][Full Text] [Related]
25. Adenosine 3',5'-monophosphate-dependent protein kinase activity in soluble thyrotropin receptor complex.
Hashizume K; DeGroot LJ
Endocrinology; 1979 Jun; 104(6):1739-44. PubMed ID: 221190
[TBL] [Abstract][Full Text] [Related]
26. Amiodarone effects on thyrotropin receptors and responses stimulated by thyrotropin and carbachol in cultured dog thyroid cells.
Rani CS
Endocrinology; 1990 Dec; 127(6):2930-7. PubMed ID: 2174339
[TBL] [Abstract][Full Text] [Related]
27. Adenosine 3',5'-monophosphate concentrations and responsiveness to thyrotropin and thyroid-stimulating immunoglobulins in normal and Graves' thyroids.
Kuzuya N; Uchimura H; Ikeda H; Chiu SC; Hamada N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1980 Jul; 51(1):59-63. PubMed ID: 6247365
[No Abstract] [Full Text] [Related]
28. Influences of cholera toxin on thyroid stimulation by thyrotropin and thyroid-stimulating antibody.
Zakarija M; McKenzie JM
Endocrinology; 1980 Dec; 107(6):2051-4. PubMed ID: 6107244
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of the Graves' immunoglobulins directed toward the thyrotropin receptor-adenylate cyclase system.
Carayon P; Adler G; Roulier R; Lissitzky S
J Clin Endocrinol Metab; 1983 Jun; 56(6):1202-8. PubMed ID: 6302125
[TBL] [Abstract][Full Text] [Related]
30. [Cyclic-AMP dependent protein kinase activity in the soluble thyrotropin receptor complex (author's transl)].
Hashizume K
Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):724-38. PubMed ID: 6248385
[TBL] [Abstract][Full Text] [Related]
31. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
32. Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices.
Laurent E; Van Sande J; Ludgate M; Corvilain B; Rocmans P; Dumont JE; Mockel J
J Clin Invest; 1991 May; 87(5):1634-42. PubMed ID: 1673689
[TBL] [Abstract][Full Text] [Related]
33. Pax-8 expression correlates with type II 5' deiodinase expression in thyroids from patients with Graves' disease.
Ambroziak M; Pachucki J; Chojnowski K; Wiechno W; Nauman J; Nauman A
Thyroid; 2003 Feb; 13(2):141-8. PubMed ID: 12699588
[TBL] [Abstract][Full Text] [Related]
34. Effects of thyroid-stimulating hormone on human thyroid carcinoma and adjacent normal tissue.
Field JB; Bloom G; Chou MC; Kerins ME; Larsen PR; Kotani M; Kariya T; Dekker A
J Clin Endocrinol Metab; 1978 Nov; 47(5):1052-8. PubMed ID: 233688
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of the adenyl cyclase-cyclic AMP system in the thyroid of the rat.
Zakarija M; McKenzie JM; Bastomsky CH
Endocrinology; 1973 May; 92(5):1349-53. PubMed ID: 4348646
[No Abstract] [Full Text] [Related]
36. [Assay of circulating thyroid stimulator determined by I- efflux].
Kobayashi I; Shoda Y; Kuwabara A; Okajima F; Kondo Y
Rinsho Byori; 1994 Sep; 42(9):938-42. PubMed ID: 7967118
[TBL] [Abstract][Full Text] [Related]
37. Proceedings: Influence of human thyroid-stimulating hormone and immunoglobulins from patients with Graves' disease on human thyroid cyclic AMP.
Holmes SD; Dirmikis SM; Martin TJ; Munro DS
J Endocrinol; 1976 Jun; 69(3):8P-9P. PubMed ID: 181521
[No Abstract] [Full Text] [Related]
38. Characterization of the thyrotropin receptor and its involvement in Graves' disease.
Kohn LD
Horiz Biochem Biophys; 1977; 3():123-63. PubMed ID: 69601
[No Abstract] [Full Text] [Related]
39. Thyrotropin receptor-adenylate cyclase system in plasma membranes from normal and diseased human thyroid glands.
Carayon P; Guibout M; Lissitzky S
J Endocrinol Invest; 1978 Oct; 1(4):321-8. PubMed ID: 229150
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
